41st Annual Educational Advertising Awards spotlight Penn Foster's integrated campaigns designed to reach new audiences across emerging digital platformsPHOENIX, April...
CHICAGO, IL / ACCESS Newswire / April 16, 2026 / The American College of Osteopathic Family Physicians (ACOFP) announces its...
BANGALORE, India, April 15, 2026 /PRNewswire/ -- Global Assistive Robotics Market Research Report:The global Assistive Robotics market is projected to grow...
Wavelet is on a mission to eliminate preventable brain injury at birth and reduce unnecessary caesarean sections, improving the lives...
Findings underpin the scientific rationale for Anavex’s targeted autophagy approach with orally administered blarcamesine Convergence of impaired autophagy and synaptic...
Oral presentations feature phentolamine ophthalmic solution 0.75%RESEARCH TRIANGLE PARK, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq:...
KALAMAZOO, Mich., April 9, 2026 /PRNewswire/ -- The article outlines key differences in coverage, eligibility, and costs that shape healthcare...
The State of Arthritis in Canada Report Card Arthritis Society Canada Arthritis Action Now unites 21 organizations, more than 100,000 patients,...
Nationwide Free Art Activation Returns for Arthritis Awareness Month ATLANTA, GA / ACCESS Newswire / April 7, 2026 / This...
Nationwide Free Art Activation Returns for Arthritis Awareness Month ATLANTA, GA / ACCESS Newswire / April 7, 2026 / This...
Investment strengthens PartsTrader's open procurement platform across the collision repair ecosystemSAN DIEGO, April 6, 2026 /PRNewswire/ -- Enlyte, a leader in...
Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA approval of motion-preserving cervical disc...
In this free webinar, learn the importance of measuring cognition in sleep medicine trials. The featured speaker will share considerations...
Axsome obtains exclusive global rights to balipodect, a potentially first-in-class selective phosphodiesterase 10A inhibitor Acquisition further expands Axsome’s industry-leading CNS...
The Roux Institute runs a program that helps expand access to care throughout MainePORTLAND, Maine, March 31, 2026 /PRNewswire/ --...
New absence capabilities strengthen the company's ability to deliver a modern and connected leave experience for employees and the HR...
Program to be externally funded by a venture philanthropy agreement through clinical proof-of-concept, including the Phase 1/2 study planned to...
Data showed 50% or more of patients reporting >50% improvement in key pain and function scales No adverse events related...
The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing...
LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately 460...